China Pacific Insurance (02601) Report Interpretation

Overview

This post-1H26 update revises China Pacific Insurance's segment forecasts while retaining Goldman Sachs' H-share Buy and A-share Neutral ratings. Stronger life investment performance is offset by a weaker P&C outlook, producing only limited changes to group profit forecasts and no change to target prices.

Core views

Goldman Sachs raises its FY26E life-insurance net-profit forecast by 4%, citing investment results in 1H26 that exceeded expectations. The benefit is partly offset by weak equity-market performance year to date through the third quarter. In the detailed forecast table, life profit is revised to Rmb36,879mn in 2026E from Rmb35,303mn, then to Rmb33,983mn and Rmb34,344mn in 2027E and 2028E, respectively; these represent revisions of +4%, +1% and 0%. The report takes a more cautious view of property-and-casualty operations. It cuts FY26-28E P&C profit by 5-8%, reflecting muted auto-insurance premium growth and higher catastrophe-related losses expected in 2H26. P&C profit estimates are Rmb8,155mn, Rmb9,853mn and Rmb10,179mn for 2026E-28E, compared with prior estimates of Rmb8,853mn, Rmb10,375mn and Rmb10,840mn. The combined-ratio forecasts are 97.2%, 97.6% and 97.5%, with the 2026E estimate 0.3 percentage points better than previously forecast but later years unchanged. At the group level, the opposing segment revisions leave FY26-28E net-profit estimates only 0-1% different. Forecast net profit is Rmb46,683mn, Rmb46,253mn and Rmb47,241mn for 2026E-28E; attributable net profit is Rmb45,499mn, Rmb45,147mn and Rmb46,037mn. EPS is forecast at Rmb4.73, Rmb4.69 and Rmb4.79. Goldman Sachs also raises DPS forecasts by 2% to Rmb1.22, Rmb1.28 and Rmb1.34, while lowering shareholders' equity forecasts by 3%, 2% and 2% after incorporating 1H26 results and mark-to-market movements in OCI assets and liabilities. For life new-business value, Goldman Sachs lowers FY26-28E NBV by 1-2% to Rmb19,331mn, Rmb20,322mn and Rmb21,566mn. It attributes the cut to a 0.3-0.5 percentage-point lower VONB margin: a higher regular-premium mix in bancassurance helps margins, but this is partly offset by a greater participating-product mix. Forecast VONB margins are 20.6%, 20.3% and 20.1%, while life embedded value forecasts rise 2-3% to Rmb507,657mn, Rmb546,490mn and Rmb586,864mn. The institution maintains its 12-month SOTP-based targets at HK$37.0 for the H shares and Rmb38.0 for the A shares, versus prices of HK$31.48 and Rmb34.21 as of 4 September 2026. These targets imply 0.9x and 1.0x FY27E P/B, respectively, compared with 0.8x and 1.0x previously. The valuation assigns CPIC Life 1.1x/1.4x FY27E P/B based on Goldman Sachs' ROA projection and values CPIC P&C at 1.1x/1.1x P/B based on FY27E ROE of 12.6%.

Analysis framework

Goldman Sachs updates its forecast model following 1H26 results, separating life, P&C and other operations. It incorporates investment performance, equity-market conditions, premium and product mix, underwriting losses, capital and OCI mark-to-market effects, then applies a sum-of-the-parts valuation using forward price-to-book multiples for the life and P&C businesses.

Methodology notes

• Valuation methodsSOTP (Sum-of-the-Parts) Valuation

  Sum-of-the-parts valuation using separate forward P/B multiples for CPIC Life and CPIC P&C.

  The report values the life and P&C businesses independently, then combines them into H- and A-share target prices.

• Valuation methodsPB valuation

  Forward price-to-book valuation linked to projected ROA and ROE.

  Goldman Sachs applies FY27E P/B multiples to the life and P&C businesses; the stated support is projected ROA for life and 12.6% FY27E ROE for P&C.

• Financial-sector metricsEmbedded Value (EV) and New Business Value (NBV)

  Life-insurance value assessment through embedded value, new-business value and VONB margin.

  The update revises NBV and VONB margin for product and channel mix changes, while also forecasting life embedded value.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• China Pacific Insurance (H) (02601.HK)

  Primary covered H-share security; rated Buy with a HK$37.0 12-month target price.

  Strengths

  Better-than-expected 1H26 life investment results and a 2% increase in DPS forecasts.

  Weaknesses

  Lower NBV forecasts and a weaker P&C earnings outlook.

  Comparison

  Target implies 0.9x FY27E P/B versus 0.8x previously.

  Risks

  Weak equity-market performance, catastrophe losses, and lower long-term bond yields could weigh on results.

• China Pacific Insurance (A) (601601.SH)

  Primary covered A-share security; rated Neutral with a Rmb38.0 12-month target price.

  Strengths

  The group forecast remains broadly stable despite offsetting segment revisions.

  Weaknesses

  P&C profit estimates are reduced and book-value estimates are lower.

  Comparison

  Target implies 1.0x FY27E P/B, unchanged from the prior multiple.

  Risks

  Lower dividend payout, higher P&C competition and weaker long-term yields are cited downside risks.

Key data

• FY26E group net profitRmb46,683mn2% above the prior forecast; FY27E and FY28E net-profit forecasts are broadly unchanged.
• FY26E life profitRmb36,879mn4% above the prior forecast, reflecting better-than-expected 1H26 investment results.
• FY26E P&C profitRmb8,155mn8% below the prior forecast, reflecting muted auto premium growth and catastrophe-related losses.
• FY26E-28E DPSRmb1.22 / Rmb1.28 / Rmb1.34Each forecast is 2% above the prior estimate.
• FY26E-28E VONB margin20.6% / 20.3% / 20.1%0.5, 0.3 and 0.3 percentage points below prior forecasts.
• H/A 12-month target pricesHK$37.0 / Rmb38.0Unchanged; based on 0.9x/1.0x FY27E P/B.

Impact & implications

The report's central implication is that stronger life investment results largely offset the reduced P&C underwriting outlook at the group-profit level. However, the mix-driven reduction in NBV margin and lower book-value estimates temper the life-insurance improvement; Goldman Sachs therefore leaves its ratings and target prices unchanged.

Risks

• Core agent headcount may fail to grow, resulting in average or below-average NBV growth versus leading peers.
• More intense competition from medium-sized competitors could increase P&C underwriting losses.
• A higher savings-product mix and capital consumption at CPIC Life could lower the dividend payout ratio.
• A further decline in long-term government-bond yields could pressure investment returns and long-term product profitability.

What to watch

• NBV growth, including new-policy sales, margin expansion and product profitability.
• P&C underwriting performance and the extent of catastrophe-related losses.
• The dividend policy and the capacity to upstream capital from P&C to the group.
• Long-term bond-yield movements and their effect on investment returns and life-product profitability.